Aflac Incorporated (NYSE:AFL) Shares Bought by Huntington National Bank

Huntington National Bank increased its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 10.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 223,793 shares of the financial services provider's stock after acquiring an additional 21,338 shares during the period. Huntington National Bank's holdings in Aflac were worth $23,149,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC grew its position in shares of Aflac by 4.0% in the third quarter. FMR LLC now owns 1,202,104 shares of the financial services provider's stock valued at $134,395,000 after purchasing an additional 45,745 shares during the period. CreativeOne Wealth LLC purchased a new stake in Aflac during the 3rd quarter worth approximately $335,000. Erste Asset Management GmbH purchased a new stake in Aflac during the 3rd quarter worth approximately $2,256,000. Benjamin Edwards Inc. acquired a new position in shares of Aflac during the third quarter valued at approximately $9,235,000. Finally, Centiva Capital LP lifted its position in shares of Aflac by 93.2% in the third quarter. Centiva Capital LP now owns 15,599 shares of the financial services provider's stock valued at $1,744,000 after acquiring an additional 7,524 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company's stock.

Insider Activity at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.90% of the company's stock.

Aflac Trading Down 2.8 %

Shares of NYSE:AFL traded down $2.87 during mid-day trading on Monday, reaching $99.11. 1,130,752 shares of the company were exchanged, compared to its average volume of 1,951,057. The firm has a market cap of $54.09 billion, a price-to-earnings ratio of 10.32, a P/E/G ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The firm's 50-day simple moving average is $106.95 and its 200 day simple moving average is $107.69.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Analyst Upgrades and Downgrades

AFL has been the subject of several research reports. Keefe, Bruyette & Woods dropped their price target on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a research report on Wednesday, February 12th. Piper Sandler increased their target price on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Wells Fargo & Company lowered their price target on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 19th. Morgan Stanley upped their price objective on shares of Aflac from $98.00 to $105.00 and gave the company an "equal weight" rating in a research note on Friday, February 28th. Finally, BMO Capital Markets began coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $104.29.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.